Gene · 4060
Papers3,622
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,622
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular matrix stiffness-The central cue for skin fibrosis. | Front Mol Biosci | 2023 | 36968277 | PubTator, text mining | PubMed |
| A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases. | Cancer Res Commun | 2023 | 36968142 | PubTator, text mining | PubMed |
| The abundances of LTF and SOD2 in amniotic fluid are potential biomarkers of gestational age and preterm birth. | Sci Rep | 2023 | 36966172 | PubTator, text mining | PubMed |
| A pediatric case of congenital stromal corneal dystrophy caused by the novel variant c.953del of the DCN gene. | Hum Genome Var | 2023 | 36964172 | PubTator, text mining | PubMed |
| Editorial: Management of borderline ovarian tumor: The best treatment is a real challenge in the era of precision medicine. | Front Surg | 2023 | 36960214 | PubTator, text mining | PubMed |
| Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study. | J Headache Pain | 2023 | 36949388 | PubTator, text mining | PubMed |
| Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial. | Ann Am Thorac Soc | 2023 | 36943405 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of tumor heterogeneity and intercellular networks in human urothelial carcinoma. | Chin Med J (Engl) | 2023 | 36939254 | PubTator, text mining | PubMed |
| Aggrecan governs intervertebral discs development by providing critical mechanical cues of the extracellular matrix. | Front Bioeng Biotechnol | 2023 | 36937743 | PubTator, text mining | PubMed |
| All-in-One digital microfluidics pipeline for proteomic sample preparation and analysis. | Chem Sci | 2023 | 36937585 | PubTator, text mining | PubMed |
| Assessing the epithelial-to-mesenchymal plasticity in a small cell lung carcinoma (SCLC) and lung fibroblasts co-culture model. | Front Mol Biosci | 2023 | 36936987 | PubTator, text mining | PubMed |
| Inter-axonal molecular crosstalk via Lumican proteoglycan sculpts murine cervical corticospinal innervation by distinct subpopulations. | Cell Rep | 2023 | 36934325 | PubTator, text mining | PubMed |
| Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies. | Nat Commun | 2023 | 36932114 | PubTator, text mining | PubMed |
| Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis. | Theranostics | 2023 | 36923539 | PubTator, text mining | PubMed |
| MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR. | Breast Cancer Res | 2023 | 36918912 | PubTator, text mining | PubMed |
| Single collagen fibrils isolated from high stress and low stress tendons show differing susceptibility to enzymatic degradation by the interstitial collagenase matrix metalloproteinase-1 (MMP-1). | Matrix Biol Plus | 2023 | 36915648 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals that endothelial cells, EndMT cells and mural cells contribute to the pathogenesis of cavernous malformations. | Exp Mol Med | 2023 | 36914857 | PubTator, text mining | PubMed |
| Methamphetamine induces cardiomyopathy through GATA4/NF-κB/SASP axis-mediated cellular senescence. | Toxicol Appl Pharmacol | 2023 | 36914120 | PubTator, text mining | PubMed |
| Serum Proteomic Analysis by Nanoflow LC-MS/MS-Based Proteomics in IgA Chronic Kidney Disease. | Clin Lab | 2023 | 36912316 | PubTator, text mining | PubMed |
| New insights into fibrotic signaling in renal cell carcinoma. | Front Cell Dev Biol | 2023 | 36910160 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4060/papers?page=30